98 related articles for article (PubMed ID: 18825404)
1. Clinical utility of serum Interleukin-1 receptor antagonist levels as a diagnostic and prognostic assay in surgical patients.
Kapoor S
Langenbecks Arch Surg; 2009 Mar; 394(2):401-2; author reply 403. PubMed ID: 18825404
[No Abstract] [Full Text] [Related]
2. Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients.
Niedźwiecki S; Stepień T; Kuzdak K; Stepień H; Krupiński R; Seehofer D; Rayes N; Ulrich F
Langenbecks Arch Surg; 2008 May; 393(3):275-80. PubMed ID: 18064485
[TBL] [Abstract][Full Text] [Related]
3. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients.
Wu Y; Han B; Sheng H; Lin M; Moore PA; Zhang J; Wu J
Int J Cancer; 2003 Jul; 105(5):724-32. PubMed ID: 12740925
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of p53 and soluble Fas ligand (sFasL) serum level concentration as indicators of apoptosis in serum of patients with benign and malignant primary follicular thyroid tumors].
Kołomecki K; Maciaszczyk P; Stepień H; Cywiński J; Cielecka J; Stepień T; Kuzdak K
Endokrynol Pol; 2006; 57(4):320-5. PubMed ID: 17006831
[TBL] [Abstract][Full Text] [Related]
6. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
7. Hyalinizing trabecular carcinoma of the thyroid gland.
Gowrishankar S; Pai SA; Carney JA
Histopathology; 2008 Mar; 52(4):529-31. PubMed ID: 18315612
[No Abstract] [Full Text] [Related]
8. Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?
Ibrahimpasic T; Ghossein R; Carlson DL; Nixon IJ; Palmer FL; Patel SG; Tuttle RM; Shaha A; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4193-7. PubMed ID: 25893415
[TBL] [Abstract][Full Text] [Related]
9. Thyroid-stimulating hormone acutely increases levels of circulating pro-coagulant microparticles.
Burger D; Gagnon A; Lochnan HA; Mahzari M; Sorisky A
Clin Endocrinol (Oxf); 2015 Aug; 83(2):285-7. PubMed ID: 25557124
[No Abstract] [Full Text] [Related]
10. [The correlation between serum thyroglobulin and iodine-131 scanning in detecting metastases in patients with a differentiated thyroid carcinoma].
Abduluakhab M; Gavrilov M; Mladenov B
Khirurgiia (Sofiia); 1997; 50(4):33-6. PubMed ID: 9739856
[TBL] [Abstract][Full Text] [Related]
11. [Extremely high level of serum thyroglobulin after surgery in a patient with follicular thyroid carcinoma. Recurrence, distant metastasis, or other etiology?].
Kobayashi K; Yokozawa T; Matsuzuka F; Miyauchi A; Kuma K
Nihon Geka Gakkai Zasshi; 2001 May; 102(5):417-20. PubMed ID: 11394007
[TBL] [Abstract][Full Text] [Related]
12. [The clinical usefulness of tumor markers in thyroid neoplastic pathology. Our experience].
Gerardi G; De Angelis P
Minerva Med; 1994 May; 85(5):237-40. PubMed ID: 8028752
[TBL] [Abstract][Full Text] [Related]
13. Mixed medullary and papillary thyroid carcinoma: A stepwise diagnosis.
Myoteri D; Dellaportas D; Carvounis E; Kondi-Pafiti A; Vassiliou I
J BUON; 2016; 21(6):1561-1562. PubMed ID: 28039723
[No Abstract] [Full Text] [Related]
14. Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels.
Pachón-Garrudo VM; Cuenca-Cuenca JI; Ruiz-Franco-Baux J; Borrego-Dorado I; Tirado-Hospital JL; Navarro-González E; Vázquez-Albertino R
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):315-21. PubMed ID: 23084014
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
[TBL] [Abstract][Full Text] [Related]
16. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers.
Sharma AK; Sarda AK; Chattopadhyay TK; Kapur MM
J Postgrad Med; 1996; 42(2):39-42. PubMed ID: 9715297
[TBL] [Abstract][Full Text] [Related]
17. Serum ferritin in thyroid cancer.
Deshpande UR; Nadkarni GD; Samuel AM
Thyroid; 1993; 3(4):301-3. PubMed ID: 8118224
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers in the diagnosis of thyroid cancer].
Slavnov VN; Markov VV; Kovalenko AE; Kovpan NA; Kvacheniuk AN
Lik Sprava; 1997; (4):31-4. PubMed ID: 9471369
[TBL] [Abstract][Full Text] [Related]
19. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid.
Suh I; Vriens MR; Guerrero MA; Griffin A; Shen WT; Duh QY; Clark OH; Kebebew E
Am J Surg; 2010 Jul; 200(1):41-6. PubMed ID: 20637335
[TBL] [Abstract][Full Text] [Related]
20. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma.
Parra-Robert M; Orois A; Augé JM; Halperin I; Filella X; Molina R
Clin Chem Lab Med; 2017 Mar; 55(3):441-446. PubMed ID: 27754959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
